EURAND N.V. EURX (NASDAQ) $ 7.51 Change: -0.72 -9.59% | Volume: 63,408
Sponsored by Click here!

EURAND NV- ORD

Company Information

Ticker Symbol: EURX
Exchange: NASD
Contact Info:
CEO/President:
Industry: Medical - Drugs / Standard Industry Code: 2834
Description: EURAND is a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and biopharmaceutical products using their proprietary drug formulation technologies.They are dedicated to the continued development and commercialization of breakthrough products that better satisfy patients\' needs. Their research efforts are focused on the development of treatment options with enhanced efficacy, superior safety and convenient dosing.

Share Information

Shares Outstanding: 45,000 (000) Market Value: 378,480 ($000)
Percentage of Inst.Shareholders: 15.80% Number of Inst.Shareholders: N/A%
Last Quarter Sales: 40.90 ($Mil.) Last Quarter Net Income: 35.98 ($Mil.)
Last Quarter EPS: -0.06 P/E Ratio: 0
Most Recent Earnings: Earnings Per Share: 0.41
Most Recent Split: Annual Dividend Rate: 0
Most Recent Dividend: Annual Dividend Yield: 0%
Data Provided By Barchart.com
CoreData does not represent, warrant, or guarantee completeness, accuracy or timeliness of its data, and shall have no liability of any kind whatsoever to any party on account of any incompleteness of, inaccuracies in or untimeliness of the CoreData content provided hereunder, or for any delay in reporting such data. CoreData expressly disclaims all warranties of fitness of the CoreData content or computations and analyses thereof for a particular purpose or use.
advertisement

Top Competitors

PFIZER INC -30.30 15.83
JOHNSON AND JOH -16.60 57.92
BRISTOL MYERS S -24.70 19.55
SCHERING PLOUGH -48.10 14.63
MERCK CO INC -54.30 26.72